Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Terminal Care | 11 | 2016 | 119 | 2.880 |
Why?
|
Advance Care Planning | 6 | 2016 | 40 | 1.760 |
Why?
|
Attitude to Death | 5 | 2013 | 39 | 1.370 |
Why?
|
Palliative Care | 8 | 2021 | 457 | 1.090 |
Why?
|
Dementia | 6 | 2013 | 484 | 1.080 |
Why?
|
Advance Directives | 4 | 2016 | 33 | 1.050 |
Why?
|
Terminally Ill | 4 | 2013 | 28 | 1.030 |
Why?
|
Decision Making | 6 | 2017 | 695 | 0.970 |
Why?
|
Pharmacists | 2 | 2021 | 99 | 0.940 |
Why?
|
Veterans | 9 | 2015 | 1764 | 0.770 |
Why?
|
Hospices | 1 | 2021 | 7 | 0.750 |
Why?
|
Cross-Cultural Comparison | 2 | 2013 | 59 | 0.710 |
Why?
|
Memory, Short-Term | 1 | 2021 | 148 | 0.660 |
Why?
|
Life Support Care | 2 | 2011 | 48 | 0.640 |
Why?
|
Physician-Patient Relations | 2 | 2015 | 446 | 0.640 |
Why?
|
Geriatrics | 4 | 2020 | 79 | 0.600 |
Why?
|
Nerve Net | 1 | 2021 | 259 | 0.580 |
Why?
|
Schizophrenia | 1 | 2021 | 332 | 0.580 |
Why?
|
Cancer Pain | 1 | 2017 | 28 | 0.540 |
Why?
|
Depression | 4 | 2022 | 1348 | 0.510 |
Why?
|
Social Values | 1 | 2015 | 48 | 0.490 |
Why?
|
Depressive Disorder | 2 | 2009 | 484 | 0.460 |
Why?
|
Cholinesterase Inhibitors | 2 | 2013 | 102 | 0.460 |
Why?
|
Drug Utilization | 2 | 2013 | 166 | 0.450 |
Why?
|
Personal Autonomy | 2 | 2013 | 202 | 0.420 |
Why?
|
Writing | 1 | 2013 | 66 | 0.400 |
Why?
|
Professional Competence | 1 | 2013 | 99 | 0.400 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 490 | 0.390 |
Why?
|
Personality | 1 | 2013 | 111 | 0.390 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 458 | 0.390 |
Why?
|
Euthanasia, Passive | 1 | 2011 | 9 | 0.360 |
Why?
|
Education, Medical, Undergraduate | 1 | 2013 | 169 | 0.360 |
Why?
|
Communication | 1 | 2015 | 541 | 0.360 |
Why?
|
Physician's Role | 2 | 2009 | 171 | 0.350 |
Why?
|
Prefrontal Cortex | 2 | 2024 | 218 | 0.340 |
Why?
|
Hypertension | 2 | 2010 | 1389 | 0.340 |
Why?
|
Brain | 2 | 2024 | 3200 | 0.330 |
Why?
|
Health Care Rationing | 2 | 2020 | 61 | 0.330 |
Why?
|
Antihypertensive Agents | 2 | 2010 | 409 | 0.330 |
Why?
|
Glaucoma, Open-Angle | 1 | 2009 | 38 | 0.310 |
Why?
|
Professional Role | 1 | 2009 | 72 | 0.310 |
Why?
|
Blindness | 1 | 2009 | 79 | 0.300 |
Why?
|
Students, Medical | 1 | 2013 | 366 | 0.300 |
Why?
|
Aged | 16 | 2020 | 21664 | 0.290 |
Why?
|
Antidepressive Agents | 2 | 2008 | 324 | 0.290 |
Why?
|
Geriatric Assessment | 1 | 2009 | 190 | 0.280 |
Why?
|
Humans | 34 | 2024 | 133455 | 0.280 |
Why?
|
Focus Groups | 3 | 2013 | 214 | 0.260 |
Why?
|
Betacoronavirus | 2 | 2020 | 309 | 0.260 |
Why?
|
Thromboembolism | 1 | 2007 | 91 | 0.250 |
Why?
|
Aged, 80 and over | 9 | 2020 | 7183 | 0.250 |
Why?
|
Male | 22 | 2024 | 65713 | 0.250 |
Why?
|
Warfarin | 1 | 2007 | 124 | 0.250 |
Why?
|
Qualitative Research | 4 | 2019 | 636 | 0.240 |
Why?
|
Drug Monitoring | 1 | 2007 | 180 | 0.240 |
Why?
|
Medication Adherence | 1 | 2009 | 338 | 0.240 |
Why?
|
Hypotension, Orthostatic | 1 | 2005 | 22 | 0.240 |
Why?
|
Drug Therapy | 1 | 2005 | 93 | 0.230 |
Why?
|
Quality of Life | 5 | 2021 | 2125 | 0.230 |
Why?
|
Coronavirus Infections | 2 | 2020 | 388 | 0.230 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 399 | 0.230 |
Why?
|
Hospitalization | 1 | 2013 | 1880 | 0.220 |
Why?
|
Inpatients | 3 | 2021 | 534 | 0.220 |
Why?
|
Gastrostomy | 1 | 2005 | 91 | 0.220 |
Why?
|
Feeding and Eating Disorders | 1 | 2005 | 76 | 0.220 |
Why?
|
Blood Pressure | 1 | 2010 | 1408 | 0.220 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2024 | 71 | 0.210 |
Why?
|
Critical Illness | 1 | 2008 | 621 | 0.210 |
Why?
|
Kidney Neoplasms | 1 | 2008 | 460 | 0.210 |
Why?
|
Caregivers | 1 | 2009 | 585 | 0.210 |
Why?
|
Female | 20 | 2024 | 71472 | 0.210 |
Why?
|
Hemorrhage | 1 | 2007 | 505 | 0.210 |
Why?
|
Primary Health Care | 1 | 2009 | 795 | 0.200 |
Why?
|
Enteral Nutrition | 1 | 2005 | 270 | 0.200 |
Why?
|
Habituation, Psychophysiologic | 1 | 2022 | 16 | 0.200 |
Why?
|
Practice Patterns, Physicians' | 3 | 2017 | 763 | 0.200 |
Why?
|
Pandemics | 2 | 2020 | 1192 | 0.190 |
Why?
|
Anticoagulants | 1 | 2007 | 598 | 0.190 |
Why?
|
Neoplasms | 1 | 2017 | 3008 | 0.190 |
Why?
|
Dopamine D2 Receptor Antagonists | 1 | 2021 | 6 | 0.180 |
Why?
|
Receptors, Dopamine D2 | 1 | 2021 | 47 | 0.180 |
Why?
|
Middle Aged | 9 | 2024 | 29299 | 0.180 |
Why?
|
Cohort Studies | 5 | 2009 | 5176 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 3818 | 0.180 |
Why?
|
Receptors, Dopamine D1 | 1 | 2021 | 88 | 0.170 |
Why?
|
Heat-Shock Response | 1 | 2020 | 35 | 0.170 |
Why?
|
Health Planning Guidelines | 1 | 2020 | 34 | 0.170 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2020 | 64 | 0.170 |
Why?
|
Suicide, Assisted | 1 | 2019 | 11 | 0.160 |
Why?
|
Chickens | 1 | 2020 | 640 | 0.160 |
Why?
|
Glycine | 1 | 2020 | 171 | 0.160 |
Why?
|
Acute-On-Chronic Liver Failure | 1 | 2020 | 80 | 0.150 |
Why?
|
Physicians | 2 | 2019 | 630 | 0.150 |
Why?
|
Patient Selection | 2 | 2017 | 732 | 0.150 |
Why?
|
Adult | 7 | 2024 | 31881 | 0.150 |
Why?
|
Prevalence | 3 | 2013 | 2654 | 0.150 |
Why?
|
Oncologists | 1 | 2017 | 29 | 0.140 |
Why?
|
Mental Disorders | 1 | 2004 | 878 | 0.130 |
Why?
|
DNA Methylation | 1 | 2024 | 1146 | 0.130 |
Why?
|
Resuscitation Orders | 1 | 2016 | 32 | 0.130 |
Why?
|
Dietary Supplements | 1 | 2020 | 498 | 0.130 |
Why?
|
California | 1 | 2016 | 141 | 0.130 |
Why?
|
United States | 8 | 2020 | 11645 | 0.130 |
Why?
|
Antipsychotic Agents | 2 | 2013 | 388 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2013 | 17413 | 0.120 |
Why?
|
Nursing Homes | 1 | 2016 | 97 | 0.120 |
Why?
|
Societies, Medical | 1 | 2019 | 757 | 0.120 |
Why?
|
United States Department of Veterans Affairs | 2 | 2017 | 705 | 0.120 |
Why?
|
Energy Metabolism | 1 | 2020 | 809 | 0.120 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 712 | 0.110 |
Why?
|
Altruism | 1 | 2013 | 25 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 379 | 0.110 |
Why?
|
Young Adult | 3 | 2024 | 9881 | 0.100 |
Why?
|
Trust | 1 | 2013 | 79 | 0.100 |
Why?
|
Empathy | 1 | 2013 | 63 | 0.100 |
Why?
|
Benzodiazepines | 1 | 2013 | 110 | 0.100 |
Why?
|
Delirium | 1 | 2013 | 61 | 0.100 |
Why?
|
Hospice Care | 1 | 2011 | 32 | 0.090 |
Why?
|
Surveys and Questionnaires | 3 | 2019 | 3986 | 0.090 |
Why?
|
Pilot Projects | 1 | 2015 | 1488 | 0.090 |
Why?
|
Risk Assessment | 2 | 2013 | 3682 | 0.090 |
Why?
|
Genetic Testing | 1 | 2017 | 1084 | 0.090 |
Why?
|
Self Report | 1 | 2013 | 551 | 0.090 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2010 | 34 | 0.080 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 116 | 0.080 |
Why?
|
Patient Readmission | 1 | 2013 | 411 | 0.080 |
Why?
|
Cultural Diversity | 1 | 2009 | 71 | 0.080 |
Why?
|
Dysthymic Disorder | 1 | 2009 | 7 | 0.080 |
Why?
|
Memantine | 1 | 2009 | 18 | 0.080 |
Why?
|
Grief | 1 | 2009 | 19 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2011 | 504 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2010 | 849 | 0.080 |
Why?
|
Professional-Family Relations | 1 | 2009 | 96 | 0.070 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2009 | 103 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2013 | 1072 | 0.070 |
Why?
|
Curriculum | 1 | 2013 | 777 | 0.070 |
Why?
|
Length of Stay | 1 | 2013 | 1374 | 0.070 |
Why?
|
Health Planning | 1 | 2007 | 16 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2017 | 1791 | 0.070 |
Why?
|
International Normalized Ratio | 1 | 2007 | 44 | 0.070 |
Why?
|
Texas | 1 | 2015 | 3681 | 0.070 |
Why?
|
Outpatients | 2 | 2005 | 267 | 0.060 |
Why?
|
Informed Consent | 1 | 2009 | 345 | 0.060 |
Why?
|
Ethics, Medical | 1 | 2009 | 403 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2013 | 789 | 0.060 |
Why?
|
Needs Assessment | 1 | 2007 | 184 | 0.060 |
Why?
|
Prazosin | 1 | 2005 | 7 | 0.060 |
Why?
|
Anxiety Disorders | 2 | 2022 | 725 | 0.060 |
Why?
|
Lisinopril | 1 | 2005 | 23 | 0.060 |
Why?
|
Furosemide | 1 | 2005 | 37 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2009 | 570 | 0.060 |
Why?
|
Hydrochlorothiazide | 1 | 2005 | 60 | 0.060 |
Why?
|
Health Services for the Aged | 1 | 2005 | 40 | 0.060 |
Why?
|
Databases, Factual | 1 | 2010 | 1243 | 0.060 |
Why?
|
Psychomotor Agitation | 1 | 2004 | 57 | 0.060 |
Why?
|
Gray Matter | 1 | 2024 | 44 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2009 | 480 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2007 | 412 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 462 | 0.050 |
Why?
|
Hospitals, Veterans | 1 | 2005 | 357 | 0.050 |
Why?
|
Patient Discharge | 1 | 2007 | 517 | 0.050 |
Why?
|
Aggression | 1 | 2004 | 232 | 0.050 |
Why?
|
Amygdala | 1 | 2022 | 87 | 0.050 |
Why?
|
Lung Diseases, Obstructive | 1 | 2001 | 34 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2007 | 677 | 0.040 |
Why?
|
Creatine | 1 | 2020 | 43 | 0.040 |
Why?
|
Animal Feed | 1 | 2020 | 83 | 0.040 |
Why?
|
District of Columbia | 1 | 2019 | 17 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2020 | 132 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2024 | 600 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 774 | 0.040 |
Why?
|
Risk Factors | 1 | 2013 | 11054 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2019 | 148 | 0.040 |
Why?
|
Arginine | 1 | 2020 | 349 | 0.040 |
Why?
|
Anxiety | 1 | 2022 | 990 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2008 | 12987 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2017 | 281 | 0.030 |
Why?
|
Diet | 1 | 2020 | 1196 | 0.030 |
Why?
|
Bibliometrics | 1 | 2011 | 37 | 0.020 |
Why?
|
Prognosis | 1 | 2020 | 5058 | 0.020 |
Why?
|
Pain Management | 1 | 2011 | 201 | 0.020 |
Why?
|
Health Resources | 1 | 2005 | 125 | 0.010 |
Why?
|
Urban Population | 1 | 2001 | 240 | 0.010 |
Why?
|
Animals | 1 | 2020 | 36278 | 0.010 |
Why?
|
Age Factors | 1 | 2005 | 2978 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2005 | 872 | 0.010 |
Why?
|